purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global RNA-Based Vaccines Market Size Analysis from 2022 to 2027

1.5.1 Global RNA-Based Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global RNA-Based Vaccines Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global RNA-Based Vaccines Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: RNA-Based Vaccines Industry Impact

Chapter 2 Global RNA-Based Vaccines Competition by Types, Applications, and Top Regions and Countries

2.1 Global RNA-Based Vaccines (Volume and Value) by Type

2.1.1 Global RNA-Based Vaccines Consumption and Market Share by Type (2016-2021)

2.1.2 Global RNA-Based Vaccines Revenue and Market Share by Type (2016-2021)

2.2 Global RNA-Based Vaccines (Volume and Value) by Application

2.2.1 Global RNA-Based Vaccines Consumption and Market Share by Application (2016-2021)

2.2.2 Global RNA-Based Vaccines Revenue and Market Share by Application (2016-2021)

2.3 Global RNA-Based Vaccines (Volume and Value) by Regions

2.3.1 Global RNA-Based Vaccines Consumption and Market Share by Regions (2016-2021)

2.3.2 Global RNA-Based Vaccines Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global RNA-Based Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global RNA-Based Vaccines Consumption by Regions (2016-2021)

4.2 North America RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.4 Europe RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.8 Africa RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

4.10 South America RNA-Based Vaccines Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America RNA-Based Vaccines Market Analysis

5.1 North America RNA-Based Vaccines Consumption and Value Analysis

5.1.1 North America RNA-Based Vaccines Market Under COVID-19

5.2 North America RNA-Based Vaccines Consumption Volume by Types

5.3 North America RNA-Based Vaccines Consumption Structure by Application

5.4 North America RNA-Based Vaccines Consumption by Top Countries

5.4.1 United States RNA-Based Vaccines Consumption Volume from 2016 to 2021

5.4.2 Canada RNA-Based Vaccines Consumption Volume from 2016 to 2021

5.4.3 Mexico RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 6 East Asia RNA-Based Vaccines Market Analysis

6.1 East Asia RNA-Based Vaccines Consumption and Value Analysis

6.1.1 East Asia RNA-Based Vaccines Market Under COVID-19

6.2 East Asia RNA-Based Vaccines Consumption Volume by Types

6.3 East Asia RNA-Based Vaccines Consumption Structure by Application

6.4 East Asia RNA-Based Vaccines Consumption by Top Countries

6.4.1 China RNA-Based Vaccines Consumption Volume from 2016 to 2021

6.4.2 Japan RNA-Based Vaccines Consumption Volume from 2016 to 2021

6.4.3 South Korea RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 7 Europe RNA-Based Vaccines Market Analysis

7.1 Europe RNA-Based Vaccines Consumption and Value Analysis

7.1.1 Europe RNA-Based Vaccines Market Under COVID-19

7.2 Europe RNA-Based Vaccines Consumption Volume by Types

7.3 Europe RNA-Based Vaccines Consumption Structure by Application

7.4 Europe RNA-Based Vaccines Consumption by Top Countries

7.4.1 Germany RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.2 UK RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.3 France RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.4 Italy RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.5 Russia RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.6 Spain RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.7 Netherlands RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.8 Switzerland RNA-Based Vaccines Consumption Volume from 2016 to 2021

7.4.9 Poland RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 8 South Asia RNA-Based Vaccines Market Analysis

8.1 South Asia RNA-Based Vaccines Consumption and Value Analysis

8.1.1 South Asia RNA-Based Vaccines Market Under COVID-19

8.2 South Asia RNA-Based Vaccines Consumption Volume by Types

8.3 South Asia RNA-Based Vaccines Consumption Structure by Application

8.4 South Asia RNA-Based Vaccines Consumption by Top Countries

8.4.1 India RNA-Based Vaccines Consumption Volume from 2016 to 2021

8.4.2 Pakistan RNA-Based Vaccines Consumption Volume from 2016 to 2021

8.4.3 Bangladesh RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia RNA-Based Vaccines Market Analysis

9.1 Southeast Asia RNA-Based Vaccines Consumption and Value Analysis

9.1.1 Southeast Asia RNA-Based Vaccines Market Under COVID-19

9.2 Southeast Asia RNA-Based Vaccines Consumption Volume by Types

9.3 Southeast Asia RNA-Based Vaccines Consumption Structure by Application

9.4 Southeast Asia RNA-Based Vaccines Consumption by Top Countries

9.4.1 Indonesia RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.2 Thailand RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.3 Singapore RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.4 Malaysia RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.5 Philippines RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.6 Vietnam RNA-Based Vaccines Consumption Volume from 2016 to 2021

9.4.7 Myanmar RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 10 Middle East RNA-Based Vaccines Market Analysis

10.1 Middle East RNA-Based Vaccines Consumption and Value Analysis

10.1.1 Middle East RNA-Based Vaccines Market Under COVID-19

10.2 Middle East RNA-Based Vaccines Consumption Volume by Types

10.3 Middle East RNA-Based Vaccines Consumption Structure by Application

10.4 Middle East RNA-Based Vaccines Consumption by Top Countries

10.4.1 Turkey RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.3 Iran RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.5 Israel RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.6 Iraq RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.7 Qatar RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.8 Kuwait RNA-Based Vaccines Consumption Volume from 2016 to 2021

10.4.9 Oman RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 11 Africa RNA-Based Vaccines Market Analysis

11.1 Africa RNA-Based Vaccines Consumption and Value Analysis

11.1.1 Africa RNA-Based Vaccines Market Under COVID-19

11.2 Africa RNA-Based Vaccines Consumption Volume by Types

11.3 Africa RNA-Based Vaccines Consumption Structure by Application

11.4 Africa RNA-Based Vaccines Consumption by Top Countries

11.4.1 Nigeria RNA-Based Vaccines Consumption Volume from 2016 to 2021

11.4.2 South Africa RNA-Based Vaccines Consumption Volume from 2016 to 2021

11.4.3 Egypt RNA-Based Vaccines Consumption Volume from 2016 to 2021

11.4.4 Algeria RNA-Based Vaccines Consumption Volume from 2016 to 2021

11.4.5 Morocco RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 12 Oceania RNA-Based Vaccines Market Analysis

12.1 Oceania RNA-Based Vaccines Consumption and Value Analysis

12.2 Oceania RNA-Based Vaccines Consumption Volume by Types

12.3 Oceania RNA-Based Vaccines Consumption Structure by Application

12.4 Oceania RNA-Based Vaccines Consumption by Top Countries

12.4.1 Australia RNA-Based Vaccines Consumption Volume from 2016 to 2021

12.4.2 New Zealand RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 13 South America RNA-Based Vaccines Market Analysis

13.1 South America RNA-Based Vaccines Consumption and Value Analysis

13.1.1 South America RNA-Based Vaccines Market Under COVID-19

13.2 South America RNA-Based Vaccines Consumption Volume by Types

13.3 South America RNA-Based Vaccines Consumption Structure by Application

13.4 South America RNA-Based Vaccines Consumption Volume by Major Countries

13.4.1 Brazil RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.2 Argentina RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.3 Columbia RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.4 Chile RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.5 Venezuela RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.6 Peru RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico RNA-Based Vaccines Consumption Volume from 2016 to 2021

13.4.8 Ecuador RNA-Based Vaccines Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in RNA-Based Vaccines Business

14.1 Pfizer

14.1.1 Pfizer Company Profile

14.1.2 Pfizer RNA-Based Vaccines Product Specification

14.1.3 Pfizer RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Roche

14.2.1 Roche Company Profile

14.2.2 Roche RNA-Based Vaccines Product Specification

14.2.3 Roche RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Sanofi-Aventis

14.3.1 Sanofi-Aventis Company Profile

14.3.2 Sanofi-Aventis RNA-Based Vaccines Product Specification

14.3.3 Sanofi-Aventis RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Abbott Laboratories

14.4.1 Abbott Laboratories Company Profile

14.4.2 Abbott Laboratories RNA-Based Vaccines Product Specification

14.4.3 Abbott Laboratories RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Arrowhead Pharmaceuticals

14.5.1 Arrowhead Pharmaceuticals Company Profile

14.5.2 Arrowhead Pharmaceuticals RNA-Based Vaccines Product Specification

14.5.3 Arrowhead Pharmaceuticals RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Benitec Biopharma

14.6.1 Benitec Biopharma Company Profile

14.6.2 Benitec Biopharma RNA-Based Vaccines Product Specification

14.6.3 Benitec Biopharma RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Calimmune Inc

14.7.1 Calimmune Inc Company Profile

14.7.2 Calimmune Inc RNA-Based Vaccines Product Specification

14.7.3 Calimmune Inc RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Dicerna

14.8.1 Dicerna Company Profile

14.8.2 Dicerna RNA-Based Vaccines Product Specification

14.8.3 Dicerna RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Gradalis

14.9.1 Gradalis Company Profile

14.9.2 Gradalis RNA-Based Vaccines Product Specification

14.9.3 Gradalis RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Quark

14.10.1 Quark Company Profile

14.10.2 Quark RNA-Based Vaccines Product Specification

14.10.3 Quark RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 RXi

14.11.1 RXi Company Profile

14.11.2 RXi RNA-Based Vaccines Product Specification

14.11.3 RXi RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Senesco

14.12.1 Senesco Company Profile

14.12.2 Senesco RNA-Based Vaccines Product Specification

14.12.3 Senesco RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Silence Therapeutics

14.13.1 Silence Therapeutics Company Profile

14.13.2 Silence Therapeutics RNA-Based Vaccines Product Specification

14.13.3 Silence Therapeutics RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Silenseed

14.14.1 Silenseed Company Profile

14.14.2 Silenseed RNA-Based Vaccines Product Specification

14.14.3 Silenseed RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Tekmira

14.15.1 Tekmira Company Profile

14.15.2 Tekmira RNA-Based Vaccines Product Specification

14.15.3 Tekmira RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Alnylam Pharmaceuticals

14.16.1 Alnylam Pharmaceuticals Company Profile

14.16.2 Alnylam Pharmaceuticals RNA-Based Vaccines Product Specification

14.16.3 Alnylam Pharmaceuticals RNA-Based Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global RNA-Based Vaccines Market Forecast (2022-2027)

15.1 Global RNA-Based Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global RNA-Based Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global RNA-Based Vaccines Value and Growth Rate Forecast (2022-2027)

15.2 Global RNA-Based Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global RNA-Based Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global RNA-Based Vaccines Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America RNA-Based Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global RNA-Based Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global RNA-Based Vaccines Consumption Forecast by Type (2022-2027)

15.3.2 Global RNA-Based Vaccines Revenue Forecast by Type (2022-2027)

15.3.3 Global RNA-Based Vaccines Price Forecast by Type (2022-2027)

15.4 Global RNA-Based Vaccines Consumption Volume Forecast by Application (2022-2027)

15.5 RNA-Based Vaccines Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology